Name: Latest research reports of Laurus Labs Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Laurus Labs Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Laurus Labs Ltd.

NSE: LAURUSLABS | BSE: 540222 | ISIN: INE947Q01028 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

701.8000 21.45 (3.15%)

NSE Jun 27, 2025 15:31 PM

New 52W High today

Volume: 3.2M

Laurus Labs Ltd.

25 Oct 2024

701.80

3.15%

Laurus Labs (SELL): Another weak quarter

Sell: Laurus Labs Ltd.

BOB Capital Markets Ltd.

Earnings miss for 2Q on our and street estimates on all fronts. Revenue/PAT came short of consensus estimates by -5%/39%

Laurus Labs Ltd. has an average target of 649.60 from 5 brokers.